132 related articles for article (PubMed ID: 37871474)
1. Generation of induced pluripotent stem cell lines from pediatric patients with congenital myotonic dystrophy (CBRCULi012-A and CBRCULi013-A) and age-matched controls (CBRCULi010-A and CBRCULi011-A).
De Serres-Bérard T; Jauvin D; Puymirat J; Chahine M
Stem Cell Res; 2023 Oct; 72():103234. PubMed ID: 37871474
[TBL] [Abstract][Full Text] [Related]
2. Lymphoblastoid cell lines derived from iPSCs of a myotonic dystrophy type 1 patient carrying 700 CTG repeats (CBRCULi007-A) and a control (CBRCULi006-A).
Chahine M; Jauvin D; Pierre M; Puymirat J; Boutjdir M
Stem Cell Res; 2023 Sep; 71():103148. PubMed ID: 37352653
[TBL] [Abstract][Full Text] [Related]
3. Generation of three myotonic dystrophy type 1 patient iPSC lines (CBRCULi018-A, CBRCULi019-A, CBRCULi020-A) derived from lymphoblastoid cell lines for disease modelling and therapeutic research.
Pierre M; Jauvin D; Puymirat J; Boutjdir M; Chahine M
Stem Cell Res; 2024 Apr; 76():103375. PubMed ID: 38490135
[TBL] [Abstract][Full Text] [Related]
4. Generation of a lymphoblastoid-derived induced pluripotent stem cell line (CBRCULi015-A) from a patient with congenital myotonic dystrophy.
De Serres-Bérard T; Jauvin D; Pouliot V; Puymirat J; Chahine M
Stem Cell Res; 2024 Jun; 77():103430. PubMed ID: 38704930
[TBL] [Abstract][Full Text] [Related]
5. Lymphoblastoids cell lines - Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG)
Martineau L; Racine V; Benichou SA; Puymirat J
Stem Cell Res; 2018 Jan; 26():103-106. PubMed ID: 29274549
[TBL] [Abstract][Full Text] [Related]
6. Generation of four myotonic dystrophy type 1 patient iPSC lines (CBRCULi002-A, CBRCULi003-A, CBRCULi004-A, CBRCULi005-A) and a control (CBRCULi001-A) derived from lymphoblastoids cell lines.
Jauvin D; Pierre M; Boutjdir M; Puymirat J; Chahine M
Stem Cell Res; 2023 Mar; 67():103037. PubMed ID: 36739767
[TBL] [Abstract][Full Text] [Related]
7. Generation of induced pluripotent stem cell line (ZZUi015-A) from a DM1 patient with cataract.
Li T; Sun H; Wang Z; Zhang Q; Chen N; Zhang K; Wang Y; Xu Y
Stem Cell Res; 2022 Jan; 58():102623. PubMed ID: 34915310
[TBL] [Abstract][Full Text] [Related]
8. Length-dependent CTG·CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells.
Du J; Campau E; Soragni E; Jespersen C; Gottesfeld JM
Hum Mol Genet; 2013 Dec; 22(25):5276-87. PubMed ID: 23933738
[TBL] [Abstract][Full Text] [Related]
9.
Visconti VV; Macrì E; D'Apice MR; Centofanti F; Massa R; Novelli G; Botta A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373276
[TBL] [Abstract][Full Text] [Related]
10. Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development.
Hale MA; Bates K; Provenzano M; Johnson NE
Hum Mol Genet; 2023 Apr; 32(9):1413-1428. PubMed ID: 36222125
[TBL] [Abstract][Full Text] [Related]
11. Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.
Ueki J; Nakamori M; Nakamura M; Nishikawa M; Yoshida Y; Tanaka A; Morizane A; Kamon M; Araki T; Takahashi MP; Watanabe A; Inagaki N; Sakurai H
Sci Rep; 2017 Feb; 7():42522. PubMed ID: 28211918
[TBL] [Abstract][Full Text] [Related]
12. Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)
André LM; van Cruchten RTP; Willemse M; Bezstarosti K; Demmers JAA; van Agtmaal EL; Wansink DG; Wieringa B
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766224
[TBL] [Abstract][Full Text] [Related]
13. Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.
Gao Y; Guo X; Santostefano K; Wang Y; Reid T; Zeng D; Terada N; Ashizawa T; Xia G
Mol Ther; 2016 Aug; 24(8):1378-87. PubMed ID: 27203440
[TBL] [Abstract][Full Text] [Related]
14. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.
Furling D; Lam le T; Agbulut O; Butler-Browne GS; Morris GE
Am J Pathol; 2003 Mar; 162(3):1001-9. PubMed ID: 12598332
[TBL] [Abstract][Full Text] [Related]
15. Myotonic dystrophy type 1 (DM1) clinical subtypes and CTCF site methylation status flanking the CTG expansion are mutant allele length-dependent.
Morales F; Corrales E; Zhang B; Vásquez M; Santamaría-Ulloa C; Quesada H; Sirito M; Estecio MR; Monckton DG; Krahe R
Hum Mol Genet; 2021 Dec; 31(2):262-274. PubMed ID: 34432028
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9.
Wang Y; Hao L; Wang H; Santostefano K; Thapa A; Cleary J; Li H; Guo X; Terada N; Ashizawa T; Xia G
Mol Ther; 2018 Nov; 26(11):2617-2630. PubMed ID: 30274788
[TBL] [Abstract][Full Text] [Related]
17. Distribution of CTG repeats at the DMPK gene in myotonic dystrophy patients and healthy individuals from the Mexican population.
Magaña JJ; Cortés-Reynosa P; Escobar-Cedillo R; Gómez R; Leyva-García N; Cisneros B
Mol Biol Rep; 2011 Feb; 38(2):1341-6. PubMed ID: 20635151
[TBL] [Abstract][Full Text] [Related]
18. Paternal transmission of the congenital form of myotonic dystrophy type 1: a new case and review of the literature.
Zeesman S; Carson N; Whelan DT
Am J Med Genet; 2002 Jan; 107(3):222-6. PubMed ID: 11807903
[TBL] [Abstract][Full Text] [Related]
19. Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice.
Lo Scrudato M; Poulard K; Sourd C; Tomé S; Klein AF; Corre G; Huguet A; Furling D; Gourdon G; Buj-Bello A
Mol Ther; 2019 Aug; 27(8):1372-1388. PubMed ID: 31253581
[TBL] [Abstract][Full Text] [Related]
20. CpG Methylation, a Parent-of-Origin Effect for Maternal-Biased Transmission of Congenital Myotonic Dystrophy.
Barbé L; Lanni S; López-Castel A; Franck S; Spits C; Keymolen K; Seneca S; Tomé S; Miron I; Letourneau J; Liang M; Choufani S; Weksberg R; Wilson MD; Sedlacek Z; Gagnon C; Musova Z; Chitayat D; Shannon P; Mathieu J; Sermon K; Pearson CE
Am J Hum Genet; 2017 Mar; 100(3):488-505. PubMed ID: 28257691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
